ACE2 and COVID-19: It is expected that infection by SARS-CoV-2 through routes with high number of virally permissive cells, such as the alveolar epithelial cells in the upper airway of respiratory system that have high level of ACE2 expression, could lead to COVID-19 progression to severe symptoms faster.